Thanks for visiting Scientific Computing World.

You're trying to access an editorial feature that is only available to logged in, registered users of Scientific Computing World. Registering is completely free, so why not sign up with us?

By registering, as well as being able to browse all content on the site without further interruption, you'll also have the option to receive our magazine (multiple times a year) and our email newsletters.

RaQualia selects Miner3D for its visual data analysis platform

Share this on social media:

RaQualia Pharma will use Miner3D as its main R&D data analytics platform.  

RaQualia, a pharmaceutical research and development company, is a spin-off of drug maker giant Pfizer. The company focuses on pain and gastrointestinal therapeutic areas and manages six drug discovery programs.  

Miner3D helps RaQualia’s scientists and researchers to better understand vast amounts of scientific data, improve leads identification and speed up research and development processes.